Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      People run from pillar to post to get insurance claim from companies: Delhi consumer commission

      People run from pillar to post to get insurance claim from companies: Delhi consumer commission

      Farhat Nasim21 March 2019 9:55 AM IST
      The Consumer Commission said medical insurance is primarily obtained for the purpose of unforeseen medical conditions and so long as there has been no...
      Sage Therapeutics gets USFDA nod to Zulresso for treating depression

      Sage Therapeutics gets USFDA nod to Zulresso for treating depression

      Farhat Nasim21 March 2019 9:50 AM IST
      In a company-funded study of new mothers with moderate or severe postpartum depression, half the women given Zulresso had depression end within 2 ½...
      USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths

      USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths

      Farhat Nasim21 March 2019 9:45 AM IST
      The clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukaemia (CLL) or acute myeloid...
      Canada to create national drug agency to cut cost of prescription medicines

      Canada to create national drug agency to cut cost of prescription medicines

      Farhat Nasim21 March 2019 9:30 AM IST
      Branded medicines cost, on average, 20 per cent more in Canada than in other advanced economies, and around 20 per cent of Canadians are uninsured or...
      NY mulls medication assisted opioid treatment in all lockups

      NY mulls medication assisted opioid treatment in all lockups

      Farhat Nasim21 March 2019 9:00 AM IST
      Experts say drugs such as methadone and suboxone can greatly improve inmates' chances of recovery and reduce the risk that they will commit other...
      Zydus Cadila gets USFDA nod to antiviral ointment Acyclovir

      Zydus Cadila gets USFDA nod to antiviral ointment Acyclovir

      Farhat Nasim20 March 2019 10:00 AM IST
      Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market generic Acyclovir ointment USP 5...
      BD gets USFDA approval for Venovo Stent to treat Venous Occlusive Disease

      BD gets USFDA approval for Venovo Stent to treat Venous Occlusive Disease

      Farhat Nasim20 March 2019 9:15 AM IST
      FRANKLIN: BD (Becton, Dickinson and Company) global medical technology company, recently announced the U.S. Food and Drug Administration has granted...
      Roche Tecentriq, chemotherapy combo wins USFDA approval for treatment of lung cancer

      Roche Tecentriq, chemotherapy combo wins USFDA approval for treatment of lung cancer

      Farhat Nasim19 March 2019 9:30 AM IST
      New Delhi: Swiss drugmaker Roche Holding AG's U.S. unit Genentech said on Monday its immunotherapy Tecentriq won approval for a tough-to-treat type of...
      United Health Group OptumRx accused of drug overcharges

      United Health Group OptumRx accused of drug overcharges

      Farhat Nasim19 March 2019 9:00 AM IST
      Yost accused OptumRx of failing for nearly three years to provide agreed-upon discounts for generic drugs purchased by injured workers submitting...
      Zydus Cadila gets USFDA nod for Valsartan, Hydrochlorothiazide tablets to treat high BP

      Zydus Cadila gets USFDA nod for Valsartan, Hydrochlorothiazide tablets to treat high BP

      Farhat Nasim18 March 2019 9:30 AM IST
      Valsartan and Hydrochlorothiazide tablets will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad.New Delhi: Zydus...
      Lupin Somerset facility gets OAI letter from USFDA

      Lupin Somerset facility gets OAI letter from USFDA

      Farhat Nasim18 March 2019 9:25 AM IST
      "The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending...
      Group with consumer friendly vibe pushes drugmakers message

      Group with consumer friendly vibe pushes drugmakers message

      Farhat Nasim18 March 2019 9:00 AM IST
      Drug prices may provide a rare bipartisan issue on which Congress and the White House could collaborate on legislation. WASHINGTON: Outside groups...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok